Biomarin image

BioMarin to buy Prosensa in $840 million deal

November 25, 2014
Sales and Marketing BioMarin, Prosensa, drisapersen, dystrophy

Rare-disease drug firm BioMarin has finalised its purchase of muscular disease specialist Prosensa in a deal worth over $840 million. …

Ulf Wiinberg image

Lundbeck chief executive resigns amid scandal

November 25, 2014
Medical Communications, Sales and Marketing Björklund, Lundbeck, stratified medical, ulf wiinberg

Ulf Wiinberg has resigned from his chief executive post at Denmark-based pharma giant Lundbeck following a beach of its rules …

natasha_weeks

Virgo Consumer Health promotes to senior team

November 25, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Virgo, natasha weeks, rebecca rhodes

Virgo has promoted its long-standing employee Natasha Weeks (pictured) to the position of director and lead of its Consumer Health …

BI image

CHMP nods several drugs through

November 24, 2014
Sales and Marketing Boehringer, CHMP, EMA, Esbriet, FDA, Sanofi, nintedanib, ofev

Ten new medicines have been recommended for approval by the EMA’s Committee for Medicinal Products for Human Use (CHMP), among …

Ebola image

Takeda: we’re working on Ebola too

November 24, 2014
Research and Development, Sales and Marketing Ebola, GSK, Gates, Obama, WHO, brett wells, pharmafile, rajeev, vaccines, venkaya, venkayya

The president of Takeda Vaccines has told Pharmafile that the Japanese firm has identified compounds that could help prevent infection …

Antibiotics image

Antibiotics: will the industry saviour please stand up

November 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Antibiotics, EAA, MRC, WHO, resistance, susie lunt

The spectre of a new ‘dark ages’ for humanity where common infections begin to kill again is increasingly making itself …

alberto_martinez_napp

New managing director for Napp Pharmaceuticals

November 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Napp, alberto, martinez

Alberto Martinez has joined Napp Pharmaceuticals in the UK as its new managing director, taking over the role from Dietmar …

ABPI image

ABPI: NHS must change to allow stratified drugs

November 21, 2014
Research and Development, Sales and Marketing ABPI, NHS, george freeman, personalised, rawal, stratified medicines

The development of stratified medicines – especially in therapy areas outside of oncology – will have a significant effect on …

Future bleak for Novartis’ myeloma drug

November 21, 2014
Medical Communications FDA, Farydak, Novartis, ixazomib, myeloma, panobinostat

Novartis suffered a major disappointment with the negative FDA panel vote for multiple myeloma candidate Farydak earlier this month, but …

johan_halen_ablynx

Ablynx looks to GSK for new chief commercial officer

November 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, johan heylan

Belgium-based biopharma firm Ablynx has appointed Johan Heylen to be its chief commercial officer and assume responsibility for all commercial …

Kadcyla image

Global drug spending set to top $1 trillion

November 20, 2014
Sales and Marketing Gilead, IMS, Kadcyla, Perjeta, drugs, hepatitis C, sovaldi, spend

Worldwide spending on drugs will reach over $1 trillion in 2014 and $1.3 trillion by 2018, according to a new …

Harvoni image

Gilead gets Harvoni boost for Europe

November 20, 2014
Sales and Marketing EU, Gilead, HCV, harvoni, hepc, ledipasvir, sofosbuvir, svaldi

Gilead Sciences’ new hepatitis C (HCV) tablet Harvoni has been approved across the European Union to treat the majority of …

Sanofi image

Sanofi showcases alirocumab at AHA

November 20, 2014
Sales and Marketing Amgen, PCSK9, Regeneron, Sanofi, aha, alirocumab, evolocumab

Sanofi and Regeneron released a battery of new Phase III data on their PCSK9 inhibitor alirocumab this week, reinforcing the …

Mark Baker image

NICE aims for earlier cancer diagnosis

November 20, 2014
Sales and Marketing Cancer, England, NHS, NICE, OECD, UK, baker

NICE is updating its guidance in a bid to help doctors spot the signs and symptoms of cancer as part …

bonnie_l

Sanofi names new board member

November 20, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, bonnie bassler

Sanofi has appointed Professor Bonnie Bassler as an independent member to sit among its board of directors. Bassler has more …

GSK image

GSK tests mHealth trial solutions

November 19, 2014
Medical Communications, Sales and Marketing Apple, GSK, Medidata, dr Vries, healthpatch, mhealth

GlaxoSmithKline is experimenting with mobile health (mHealth) devices linked to cloud services in clinical trials as part of a bid …

AZ image

AZ predicts strong growth ahead of Pfizer deadline

November 19, 2014
Sales and Marketing AZD9291, AstraZeneca, Pfizer, Soriot, definiens

AstraZeneca has announced that it expects to deliver revenues of over $45 billion by 2023 as it makes its final …

Reckitt image

Reckitt finalises pharmaceutical demerger plans

November 19, 2014
Business Services, Sales and Marketing Reckitt Benckiser Pharmaceuticals, cillit bang, indivior, suboxone

Reckitt Benckiser has confirmed its plans to spin-off its pharmaceutical portfolio from its core consumer products business. Final details of …

Advair image

Europe must prepare for COPD ‘timebomb’

November 19, 2014
Sales and Marketing COPD, Europe, European COPD Coalition, Spiriva, asthma, chronic obstructive pulmonary disease

Health services in Europe are not making sufficient effort to cope with the escalating burden of chronic obstructive pulmonary disease …

NICE wants more Xolair data

November 19, 2014
Sales and Marketing Genentech, NHS, NICE, Novartis, UK, Xolair, hives, omalizumab

 Novartis has been asked in draft guidance to give NICE more information before the watchdog can recommend its veteran asthma …

The Gateway to Local Adoption Series

Latest content